Skip to main content Accessibility help

Beyond the Bundle: A Survey of Central Line–Associated Bloodstream Infection Prevention Practices Used in US and Canadian Pediatric Hospitals

  • Sarah B. Klieger (a1), Gail Potter-Bynoe (a2), Caroline Quach (a3), Thomas J. Sandora (a4) and Susan E. Coffin (a1)...


We surveyed US and Canadian pediatric hospitals about their use of central line-associated bloodstream infection (CLABSI) prevention strategies beyond typical insertion and maintenance bundles. We found wide variation in supplemental strategies across hospitals and in their penetration within hospitals. Future studies should assess specific adjunctive prevention strategies and CLABSI rates.


Corresponding author

Division of Infectious Diseases and Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, 3535 Market Street, Suite 1519, Philadelphia, PA 19104 (


Hide All
1.Miller, MR, Niedner, MF, Huskins, WC, et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics 2011;128(5):e1077e1083. Published October 24, 2011. Accessed February 8, 2013.
2.Schulman, J, Stricof, R, Stevens, TP, et al. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics 2011;127(3):436444.
3.Dudeck, MA, Horan, TC, Peterson, KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2010, device-associated module. Am J Infect Control 2011;39(10):798816.
4.Hong, H, Morrow, DF, Sandora, TJ, Priebe, GP. Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity. Am J Infect Control 2013; 41 (8):e77e79. Published February 7,2013. Accessed April 3, 2013.
5.Climo, MW, Sepkowitz, KA, Zuccotti, G, et al. The effect of daily bathing with Chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009;37(6): 18581865.
6.Tamma, PD, Aucott, SW, Milstone, AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010;31(8):846849.
7.FDA/Center for Drug Evaluation and Research. Drugs@FDA: FDA approved drug products. ChloraPrep: labeling revision, August 16, 2102. Food and Drug Administration website, Accessed April 7, 2013.


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed